A more accurate estimate of the ischemic stroke risk in patients hospitalized with COVID-19 infection has come from a large American Heart Association registry...
Most postvaccination symptoms are expected and not serious, although clinicians should be ready to manage the rare case of anaphylaxis.
The FDA issued an alert about the potential of mutations, including the B.1.1.7 variant, affecting molecular COVID-19 tests. However, regulators said that risk...
Professor Karol Sikora didn’t think a 4 week delay in cancer treatment would matter until he read 'shattering' results in a recent BMJ paper.
UK health bodies have defined the syndrome known as long COVID ahead of developing a diagnosis and treatment guideline.
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurologic condition is linked to the vaccine.
The benefits emerged early and continued to accrue through the trial, with no suggestion of attenuation during up to 5 years of treatment.
The program's director also said any vaccine will go through a full FDA approval process.